Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of dapoxetine compared to
placebo in men with premature ejaculation and erectile dysfunction who are currently being
treated with a phosphodiesterase-5 inhibitor (ie, sildenafil, vardenafil, or tadalafil) for
erectile dysfunction.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.